Hep G2 Cells

"Hep G2 Cells" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A human liver tumor cell line used to study a variety of liver-specific metabolic functions.

Descriptor ID	D056945
MeSH Number(s)	A11.251.860.180.432 A11.436.348.500
Concept/Terms	Hep G2 Cells Hep G2 Cells Cell, Hep G2 Cells, Hep G2 Hep G2 Cell HepG2 Cells Cell, HepG2 Cells, HepG2 HepG2 Cell Hep G2 Cell Line Hepatoblastoma G2 Cell Line Cell Line, Hep G2 Cell Line, Hepatoblastoma G2

Below are MeSH descriptors whose meaning is more general than "Hep G2 Cells".

Anatomy [A]
Cells [A11]
Cells, Cultured [A11.251]
Tumor Cells, Cultured [A11.251.860]
Cell Line, Tumor [A11.251.860.180]
Hep G2 Cells [A11.251.860.180.432]
Epithelial Cells [A11.436]
Hepatocytes [A11.436.348]
Hep G2 Cells [A11.436.348.500]

Below are MeSH descriptors whose meaning is related to "Hep G2 Cells".

Below are MeSH descriptors whose meaning is more specific than "Hep G2 Cells".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Hep G2 Cells" by people in this website by year, and whether "Hep G2 Cells" was a major or minor topic of these publications.

Bar chart showing 47 publications over 14 distinct years, with a maximum of 8 publications in 2015

To see the data from this visualization as text, click here.

Year	Minor Topic	Total
2010	3	3
2011	3	3
2012	4	4
2013	6	6
2014	1	1
2015	8	8
2016	4	4
2017	2	2
2018	7	7
2019	2	2
2021	3	3
2023	1	1
2024	2	2
2025	1	1

Below are the most recent publications written about "Hep G2 Cells" by people in Profiles.

Srour AM, El-Bayaa MN, Temirak A, Alanzy AL, Awad HM, Saleh A, Saleh MG, El-Sayed WA. New benzimidazole-triazole glycoconjugates as anti-cancer agents and EGFR inhibitors. Sci Rep. 2025 Jul 15; 15(1):25514.

View in: PubMed
Wang Q, Huang N, Psaltis JB, Gahtani RM, Yan G, Lu D, Cahalan SR, Shi X, Copeland RL, Haddad BR, Martin MB. Activation of estrogen-related receptor ? by calcium and cadmium. Front Endocrinol (Lausanne). 2024; 15:1400022.

View in: PubMed
Rosado-Qui?ones AM, Col?n-Lorenzo EE, Pala ZR, Bosch J, Kudyba K, Kudyba H, Leed SE, Roncal N, Baerga-Ortiz A, Roche-Lima A, Gerena Y, Fidock DA, Roth A, Vega-Rodr?guez J, Serrano AE. Novel hydrazone compounds with broad-spectrum antiplasmodial activity and synergistic interactions with antimalarial drugs. Antimicrob Agents Chemother. 2024 06 05; 68(6):e0164323.

View in: PubMed
Hasan KM, Parveen M, Pena A, Bautista F, Rivera JC, Huerta RR, Martinez E, Espinoza-Derout J, Sinha-Hikim AP, Friedman TC. Fatty Acid Excess Dysregulates CARF to Initiate the Development of Hepatic Steatosis. Cells. 2023 04 01; 12(7).

View in: PubMed
Ayala-Marin YM, Grant AH, Rodriguez G, Kirken RA. Quadruple and Truncated MEK3 Mutants Identified from Acute Lymphoblastic Leukemia Promote Degradation and Enhance Proliferation. Int J Mol Sci. 2021 Nov 11; 22(22).

View in: PubMed
Karthikeyan C, Tharmalingam N, Varaprasad K, Mylonakis E, Yallapu MM. Biocidal and biocompatible hybrid nanomaterials from biomolecule chitosan, alginate and ZnO. Carbohydr Polym. 2021 Nov 15; 274:118646.

View in: PubMed
Nyamwihura RJ, Zhang H, Collins JT, Crown O, Ogungbe IV. Nopol-Based Quinoline Derivatives as Antiplasmodial Agents. Molecules. 2021 Feb 14; 26(4).

View in: PubMed
Yao Z, Di Poto C, Mavodza G, Oliver E, Ressom HW, Sherif ZA. DNA Methylation Activates TP73 Expression in Hepatocellular Carcinoma and Gastrointestinal Cancer. Sci Rep. 2019 12 18; 9(1):19367.

View in: PubMed
Anand P, Filipenko P, Huaman J, Lyudmer M, Hossain M, Santamaria C, Huang K, Ogunwobi OO, Holford M. Selective Inhibition of Liver Cancer Cells Using Venom Peptide. Mar Drugs. 2019 Oct 17; 17(10).

View in: PubMed
Gu Y, Wei X, Sun Y, Gao H, Zheng X, Wong LL, Jin L, Liu N, Hernandez B, Peplowska K, Zhao X, Zhan QM, Feng XH, Tang ZY, Ji J. miR-192-5p Silencing by Genetic Aberrations Is a Key Event in Hepatocellular Carcinomas with Cancer Stem Cell Features. Cancer Res. 2019 03 01; 79(5):941-953.

View in: PubMed

People

Explore

Similar Concepts

Top Journals